Papadimitriou, ID;
Lockey, SJ;
Voisin, S;
Herbert, AJ;
Garton, F;
Houweling, PJ;
Cieszczyk, P;
... Eynon, N; + view all
(2018)
No association between ACTN3 R577X and ACE I/D polymorphisms and endurance running times in 698 Caucasian athletes.
BMC Genomics
, 19
, Article 13. 10.1186/s12864-017-4412-0.
Preview |
Text
s12864-017-4412-0.pdf - Published Version Download (723kB) | Preview |
Abstract
BACKGROUND: Studies investigating associations between ACTN3 R577X and ACE I/D genotypes and endurance athletic status have been limited by small sample sizes from mixed sport disciplines and lack quantitative measures of performance. AIM: To examine the association between ACTN3 R577X and ACE I/D genotypes and best personal running times in a large homogeneous cohort of endurance runners. METHODS: We collected a total of 1064 personal best 1500, 3000, 5000 m and marathon running times of 698 male and female Caucasian endurance athletes from six countries (Australia, Greece, Italy, Poland, Russia and UK). Athletes were genotyped for ACTN3 R577X and ACE ID variants. RESULTS: There was no association between ACTN3 R577X or ACE I/D genotype and running performance at any distance in men or women. Mean (SD) marathon times (in s) were for men: ACTN3 RR 9149 (593), RX 9221 (582), XX 9129 (582) p = 0.94; ACE DD 9182 (665), ID 9214 (549), II 9155 (492) p = 0.85; for women: ACTN3 RR 10796 (818), RX 10667 (695), XX 10675 (553) p = 0.36; ACE DD 10604 (561), ID 10766 (740), II 10771 (708) p = 0.21. Furthermore, there were no associations between these variants and running time for any distance in a sub-analysis of athletes with personal records within 20% of world records. CONCLUSIONS: Thus, consistent with most case-control studies, this multi-cohort quantitative analysis demonstrates it is unlikely that ACTN3 XX genotype provides an advantage in competitive endurance running performance. For ACE II genotype, some prior studies show an association but others do not. Our data indicate it is also unlikely that ACE II genotype provides an advantage in endurance running.
Type: | Article |
---|---|
Title: | No association between ACTN3 R577X and ACE I/D polymorphisms and endurance running times in 698 Caucasian athletes |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1186/s12864-017-4412-0 |
Publisher version: | http://dx.doi.org/10.1186/s12864-017-4412-0 |
Language: | English |
Additional information: | © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
Keywords: | ACTN3, ACE, Genomics, Athletic performance, Endurance, Champions, ANGIOTENSIN-CONVERTING ENZYME, ELITE ENDURANCE, EPIGENETIC REGULATION, HERITAGE FAMILY, ID POLYMORPHISM, GENE VARIANTS, PERFORMANCE, GENOTYPE, MUSCLE, POWER |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci > Department of Targeted Intervention |
URI: | https://discovery.ucl.ac.uk/id/eprint/10042463 |
Archive Staff Only
View Item |